Skip to main content
Top
Published in: Gut Pathogens 1/2018

Open Access 01-12-2018 | Letter to the Editor

Towards ending viral hepatitis as a public health threat: translating new momentum into concrete results in South-East Asia

Author: Poonam Khetrapal Singh

Published in: Gut Pathogens | Issue 1/2018

Login to get access

Excerpt

We are living through a “golden age” of global health with respect to communicable diseases. As a result of scientific breakthroughs, global solidarity and focused funding, mortality associated with leading communicable diseases is on the decline. Indeed, since 2000, the progress in combatting the leading communicable diseases (HIV, tuberculosis and malaria) has prompted the global community to commit to end these epidemics once and for all by 2030. …
Literature
1.
go back to reference WHO. Global hepatitis report 2017. Geneva: Global Hepatitis Programme, Department of HIV/AIDS, World Health Organization; 2017. WHO. Global hepatitis report 2017. Geneva: Global Hepatitis Programme, Department of HIV/AIDS, World Health Organization; 2017.
2.
go back to reference UNAIDS. Fact sheet—latest statistics on the status of the AIDS epidemic. World AIDS day. Geneva: UNAIDS; 2017. UNAIDS. Fact sheet—latest statistics on the status of the AIDS epidemic. World AIDS day. Geneva: UNAIDS; 2017.
3.
go back to reference WHO. Global tuberculosis report 2017. Geneva: World Health Organization; 2017. WHO. Global tuberculosis report 2017. Geneva: World Health Organization; 2017.
4.
go back to reference WHO. Global health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis. Geneva: Global Hepatitis Programme, Department of HIV/AIDS, World Health Organization; 2016. WHO. Global health sector strategy on viral hepatitis 2016–2021: towards ending viral hepatitis. Geneva: Global Hepatitis Programme, Department of HIV/AIDS, World Health Organization; 2016.
6.
go back to reference Gupta V, Kumar A, Sharma P, Arora A. Newer direct-acting antivirals for hepatitis C virus infection: perspectives for India. Indian J Med Res. 2017;146(1):23–33.CrossRefPubMedPubMedCentral Gupta V, Kumar A, Sharma P, Arora A. Newer direct-acting antivirals for hepatitis C virus infection: perspectives for India. Indian J Med Res. 2017;146(1):23–33.CrossRefPubMedPubMedCentral
7.
go back to reference Khwairakpam G. TREAT Asia/amfAR, Bangkok. In: Presented at 20th Bangkok international symposium on HIV medicine. 2018. Khwairakpam G. TREAT Asia/amfAR, Bangkok. In: Presented at 20th Bangkok international symposium on HIV medicine. 2018.
8.
go back to reference Childs L, Roesel S, Tohme RA. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992–2015. Vaccine. 2018;36(1):6–14.CrossRefPubMed Childs L, Roesel S, Tohme RA. Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992–2015. Vaccine. 2018;36(1):6–14.CrossRefPubMed
9.
go back to reference Data collected by WHO SEARO from Member countries in the region in preparation for the Regional Action Plan for Hepatitis 2016–2021. Data collected by WHO SEARO from Member countries in the region in preparation for the Regional Action Plan for Hepatitis 2016–2021.
Metadata
Title
Towards ending viral hepatitis as a public health threat: translating new momentum into concrete results in South-East Asia
Author
Poonam Khetrapal Singh
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2018
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-018-0237-x

Other articles of this Issue 1/2018

Gut Pathogens 1/2018 Go to the issue